About LenioBio
LenioBio is a company based in Dusseldorf (Germany) founded in 2016 by Remberto Martis and Hakon Birgisson.. LenioBio has raised $13.01 million across 7 funding rounds from investors including EIT Food, European Union and Eureka Network. The company has 18 employees as of December 31, 2020. LenioBio offers products and services including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression. LenioBio operates in a competitive market with competitors including PrognomiQ, PreOmics, Vivostat, ACRO Biosystems and List Biological Laboratories, among others.
- Headquarter Dusseldorf, Germany
- Employees 18 as on 31 Dec, 2020
- Founders Remberto Martis, Hakon Birgisson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Leniobio Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.01 M (USD)
in 7 rounds
-
Latest Funding Round
$4.33 M (USD), Grant
Jul 23, 2025
-
Investors
EIT Food
& 5 more
-
Employee Count
18
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LenioBio
LenioBio offers a comprehensive portfolio of products and services, including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables rapid and scalable protein production for research.
Offers expert services for challenging protein targets.
Facilitates efficient protein expression in high-throughput setups.
Unlock access to complete
Funding Insights of LenioBio
LenioBio has successfully raised a total of $13.01M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $4.33 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $4.3M
-
First Round
First Round
(23 Aug 2019)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Grant - LenioBio | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - LenioBio | Valuation |
investors |
|
| May, 2022 | Amount | Grant - LenioBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LenioBio
LenioBio has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Food, European Union and Eureka Network. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Early-stage tech companies are invested in by Bridford Group.
|
Founded Year | Domain | Location | |
|
Food safety testing services are provided by EIT Food.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LenioBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LenioBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Leniobio Comparisons
Competitors of LenioBio
LenioBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, Vivostat, ACRO Biosystems and List Biological Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| domain | founded_year | HQ Location |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| domain | founded_year | HQ Location |
Recombinant proteins are manufactured to support cancer immunotherapy efforts.
|
|
| domain | founded_year | HQ Location |
Specializes in the production of research reagents
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Leniobio
Frequently Asked Questions about LenioBio
When was LenioBio founded?
LenioBio was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is LenioBio located?
LenioBio is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Who is the current CEO of LenioBio?
Remberto Martis is the current CEO of LenioBio. They have also founded this company.
Is LenioBio a funded company?
LenioBio is a funded company, having raised a total of $13.01M across 7 funding rounds to date. The company's 1st funding round was a Grant of $2.9M, raised on Aug 23, 2019.
How many employees does LenioBio have?
As of Dec 31, 2020, the latest employee count at LenioBio is 18.
What does LenioBio do?
LenioBio was founded in 2016 in Dusseldorf, Germany, and operates in the biotechnology sector. Cell-free protein expression kits are developed and supplied, with the ALiCE platform serving as the primary eukaryotic system for handling difficult-to-express proteins. Active energy regeneration is incorporated, along with essential components for protein folding, disulfide bonding, and glycosylation, supporting discovery, development, and production processes.
Who are the top competitors of LenioBio?
What products or services does LenioBio offer?
LenioBio offers ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression.
Who are LenioBio's investors?
LenioBio has 6 investors. Key investors include EIT Food, European Union, Eureka Network, EIC Fund, and Bridford Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.